TrialJournal of acquired immune deficiency syndromes (1999)2015

Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial.

Sharon Walmsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.